Sanofi (SNY) Interest Coverage Ratio (2009 - 2026)

Sanofi's (SNY) quarterly Interest Coverage Ratio came in at 11.92 in Q1 2026, down 11.07% year-on-year from 13.4 in Q1 2025, and down 239.85% quarter-over-quarter from 8.52 in Q4 2025.

Sanofi (SNY) Interest Coverage Ratio (2009 - 2026) Analysis & Trends

Sanofi has disclosed Interest Coverage Ratio across 18 years of filings, most recently posting 11.92 for Q1 2026.

  • Interest Coverage Ratio for Q1 2026 came in at 11.92, down 11.07% year-over-year; the trailing twelve-month figure through Mar 2026 was 4.19 (up 1.45% YoY), and the FY2025 annual result was 11.27, up 66.72% from the prior year.
  • Interest Coverage Ratio came in at 11.92 for Q1 2026 at Sanofi, down from 8.52 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 8.52 in Q4 2025 to a low of 27.24 in Q1 2022.
  • The 5-year median for Interest Coverage Ratio is 10.1 (2023), against an average of 10.42.
  • Across the five-year window, Interest Coverage Ratio tumbled 132.81% in 2022 and soared 1695.54% in 2025, its largest moves.
  • Sanofi's Interest Coverage Ratio stood at 9.32 in 2022, then surged by 42.28% to 5.38 in 2023, then surged by 90.08% to 0.53 in 2024, then surged by 1695.54% to 8.52 in 2025, then tumbled by 239.85% to 11.92 in 2026.
  • The last three Interest Coverage Ratio figures came in at 11.92 (Q1 2026), 8.52 (Q4 2025), and 12.55 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -13.73
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn -
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 23.39
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn -
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn -
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 4.06
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 10.78
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Sanofi 63.47 Mn -6.87 Bn 9.49 Bn -11.92

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.92
Dec 31, 2025 8.52
Sep 30, 2025 -12.55
Jun 30, 2025 -9.96
Mar 31, 2025 -10.73
Dec 31, 2024 -0.53
Sep 30, 2024 -13.88
Jun 30, 2024 -4.56
Mar 31, 2024 -5.00
Dec 31, 2023 -5.38
Sep 30, 2023 -10.10
Jun 30, 2023 -9.20
Mar 31, 2023 -14.66
Dec 31, 2022 -9.33
Sep 30, 2022 -26.45
Jun 30, 2022 -14.18
Mar 31, 2022 -27.24
Dec 31, 2021 -4.01
Sep 30, 2021 -34.85
Jun 30, 2021 -17.10